CompletedNot Applicable

Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit

France179 participantsStarted 2017-04-01

Plain-language summary

There is a lack of data whether colonization and infection with Enterobacteriaceae of the third group (EB3) affect the outcomes for ICU patients. This study evaluated the effects of EB3 colonization and infection on ICU mortality, ICU length of stay (LOS) and broad-spectrum antibiotic exposure. We focused on the sub type Enterobacter regarding its a priori higher risk of resistance.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adults critically ill patients admitted to the the participating ICUs during the study period * with colonization and/or infection with a third group enterobacteriacea * and with a lenght of stay \> 24h Exclusion Criteria: * minors patients * lenght of stay \< 24h

What they're measuring

all cause mortality

Timeframe: Day 180

Trial details

NCT IDNCT04528043

SponsorCentral Hospital, Nancy, France

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-01-10

View on ClinicalTrials.gov More Critically Ill trials